TANDEM DIABETES CARE INC (TNDM) › Operating Cash FlowTANDEM DIABETES CARE INC (TNDM) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$61.17M2017: -$66.14M2018: -$8.32M2019: $41.91M2020: $24.67M2021: $111.36M2022: $50.46M2023: -$31.81M2024: $24.23M2025: -$9.72M-$9.72M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$9.72M-140.1%2024$24.23M+176.2%2023-$31.81M-163.0%2022$50.46M-54.7%2021$111.36M+351.4%2020$24.67M-41.1%2019$41.91M+603.7%2018-$8.32M+87.4%2017-$66.14M-8.1%2016-$61.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share